VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,363 | -32.3% | 16,821 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $192,600 | +69.5% | 16,821 | +58.0% | 0.00% | 0.0% |
| Q3 2020 | $113,625 | -15.5% | 10,649 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $134,390 | +37.9% | 10,649 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $97,438 | -34.4% | 10,649 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $148,554 | -18.9% | 10,649 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $183,269 | -36.8% | 10,649 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $289,866 | +42.2% | 10,649 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $203,822 | +103.6% | 10,649 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $100,101 | -50.3% | 10,649 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $201,479 | -3.1% | 10,649 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $208,000 | +44.4% | 10,649 | +38.6% | 0.00% | 0.0% |
| Q1 2018 | $144,000 | +12.5% | 7,685 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $128,000 | – | 7,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |